191 related articles for article (PubMed ID: 10545613)
1. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.
Chiurazzi P; Pomponi MG; Pietrobono R; Bakker CE; Neri G; Oostra BA
Hum Mol Genet; 1999 Nov; 8(12):2317-23. PubMed ID: 10545613
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
[TBL] [Abstract][Full Text] [Related]
3. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
[TBL] [Abstract][Full Text] [Related]
4. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.
Coffee B; Zhang F; Ceman S; Warren ST; Reines D
Am J Hum Genet; 2002 Oct; 71(4):923-32. PubMed ID: 12232854
[TBL] [Abstract][Full Text] [Related]
5. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
Coffee B; Zhang F; Warren ST; Reines D
Nat Genet; 1999 May; 22(1):98-101. PubMed ID: 10319871
[TBL] [Abstract][Full Text] [Related]
6. In vitro reactivation of the FMR1 gene involved in fragile X syndrome.
Chiurazzi P; Pomponi MG; Willemsen R; Oostra BA; Neri G
Hum Mol Genet; 1998 Jan; 7(1):109-13. PubMed ID: 9384610
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome.
Biacsi R; Kumari D; Usdin K
PLoS Genet; 2008 Mar; 4(3):e1000017. PubMed ID: 18369442
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
[TBL] [Abstract][Full Text] [Related]
9. Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation.
Tabolacci E; De Pascalis I; Accadia M; Terracciano A; Moscato U; Chiurazzi P; Neri G
Pharmacogenet Genomics; 2008 Aug; 18(8):738-41. PubMed ID: 18622267
[TBL] [Abstract][Full Text] [Related]
10. Transcription of the FMR1 gene in individuals with fragile X syndrome.
Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
[TBL] [Abstract][Full Text] [Related]
11. Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription.
Kumari D; Usdin K
Hum Mol Genet; 2014 Dec; 23(24):6575-83. PubMed ID: 25055869
[TBL] [Abstract][Full Text] [Related]
12. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics, fragile X syndrome and transcriptional therapy.
Tabolacci E; Chiurazzi P
Am J Med Genet A; 2013 Nov; 161A(11):2797-808. PubMed ID: 24123753
[TBL] [Abstract][Full Text] [Related]
14. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.
Tassone F; Hagerman RJ; Loesch DZ; Lachiewicz A; Taylor AK; Hagerman PJ
Am J Med Genet; 2000 Sep; 94(3):232-6. PubMed ID: 10995510
[TBL] [Abstract][Full Text] [Related]
15. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
Salat U; Bardoni B; Wöhrle D; Steinbach P
J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
[TBL] [Abstract][Full Text] [Related]
16. Deletion in the FMR1 gene in a fragile-X male.
Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
[TBL] [Abstract][Full Text] [Related]
17. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
[TBL] [Abstract][Full Text] [Related]
18. Loss of FMR1 hypermethylation in somatic cell heterokaryons.
Stoyanova V; Rossetti S; VAN Unen L; Oostra BA; Hoogeveen AT
FASEB J; 2004 Dec; 18(15):1964-6. PubMed ID: 15377638
[TBL] [Abstract][Full Text] [Related]
19. Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated
Kumari D; Sciascia N; Usdin K
Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230785
[TBL] [Abstract][Full Text] [Related]
20. Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene.
Milà M; Castellví-Bel S; Sánchez A; Lázaro C; Villa M; Estivill X
J Med Genet; 1996 Apr; 33(4):338-40. PubMed ID: 8730293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
